Back to STATE STREET CORP STATE STREET CORP

ALXNALXN
9 quarters

Position history for STATE STREET CORPSTATE STREET CORP's holdings in ALEXION PHARMACEUTICALS INC

As of its Q2 2021 13F, State Street held 10,033,808 shares of ALXN (Alexion Pharmaceuticals), worth $1.8B. State Street's 13F filings listed ALXN from Q3 2019 to Q2 2021, 8 quarterly filings. ALXN was 0.1% of State Street's reported 13F portfolio.

Final Value

$0

Final Shares

0

Total Value Change

-$1.1B

Total Shares Change

-10.9M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2021-Q3
Latest
Exited
0
-100.0%
$00.0%—
0
2021-Q2
Increased
10M
+1.6%
$1.8B0.1%—
32
2021-Q1
Decreased
9.9M
-7.1%
$1.5B0.1%—
0
2020-Q4
Decreased
10.6M
-4.6%
$1.7B0.1%—
0
2020-Q3
Increased
11.1M
+0.6%
$1.3B0.1%—
32
2020-Q2
Decreased
11.1M
-0.1%
$1.2B0.1%—
0
2020-Q1
Increased
11.1M
+1.1%
$995.1M0.1%—
32
2019-Q4
Increased
11M
+0.8%
$1.2B0.1%—
32
2019-Q3
First report
10.9M
-
$1.1B0.1%—
0

Other major holders of ALXN: FMR LLC, FARALLON CAPITAL MANAGEMENT, L.L.C., JENNISON ASSOCIATES LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used